Add your reaction
In 2013, The National Institute of Biological Imaging and Bioengineering (NIBIB) of National Institutes of Health (NIH) awarded more than $6.4 million for the continuation of the Bioengineering Research Partnership (BRP) Raman Flow Cytometry for Drug Discovery and Diagnostics.
This multidisciplinary effort is led by Scintillon's Institute Professor John Nolan. The partnership aims to extend the multiparameter capabilities of flow cytometry by measuring Raman spectra from individual cells in flow. We are developing nanoparticle surface enhanced Raman scattering (SERS) tags, a new generation of spectral flow cytometers that can measure high resolution Raman spectra from individual cells, and software for Raman flow cytometry data analysis.